View Full Version : Immunotherapy successful against deadly breast cancer
A new trial confirms that a combination of immunotherapy and chemotherapy boosts survival rates for people with triple-negative breast cancer.
More... (https://www.medicalnewstoday.com/articles/323408.php)
donocco
10-24-2018, 12:09 PM
The new imunotherapy drug isnt really new. it is another PD1 inhibitor with a brand name of Tecentriq. My computer was down and I was a bit frustrated because I was curious about Tecentriq thinking it was something new. I printed out the package insert and will read it today but my educated guess is Opdivo or Keytruda added to the chemo would give the same results as Tecentriq. I hope Im wrong
Paul
vBulletin® v3.8.7, Copyright ©2000-2026, vBulletin Solutions, Inc.